Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LZM005 |
Trade Name | |
Synonyms | LZ-M005|LZ M005 |
Drug Descriptions |
LZM005 is an ERBB2 (HER2)-targeted antibody with increased affinity for domain II, which may have antitumor activity (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 1042). |
DrugClasses | HER2 (ERBB2) Antibody 76 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Docetaxel + LZM005 + Trastuzumab | Docetaxel LZM005 Trastuzumab | 0 | 0 |
LZM005 | LZM005 | 0 | 0 |